
A team of researchers from the University of Ottawa has discovered in a new study that myocardial infarction (heart attack) can trigger inflammatory responses within the brain, thereby increasing the likelihood of depression, anxiety disorders, and cognitive impairments. The findings of this research have been published in the journal Advanced Science.
The specialists identified that a significant consequence of suffering a heart attack is a sharp elevation in methylglyoxal, a harmful byproduct of metabolic processes. This compound has the potential to permeate brain tissue and accumulate in regions responsible for memory, emotional regulation, and thought processes.
According to the researchers, methylglyoxal initiates inflammatory cascades and causes damage to neurons. The scientists concluded that this mechanism offers a partial explanation for the heightened risk of psychological and neurological complications observed in patients following heart attacks.
The research team points out that the incidence of depression and anxiety disorders nearly triples after a heart attack. Furthermore, patients who have experienced a heart attack are more prone to recurrent cardiovascular events and exhibit a higher mortality rate.
Experiments conducted on rodents revealed alterations in multiple brain regions following a cardiac event. Persistent inflammation and the accumulation of damaging metabolites could potentially lead to memory deterioration and even contribute to the development of dementia in the future.
As part of their investigation, the scientists also successfully engineered a novel peptide designed to bind with methylglyoxal, thereby mitigating its detrimental effects on brain cells. This compound is currently being evaluated as a potential therapeutic agent for protecting the brain post-heart attack and will undergo further testing in subsequent studies.